Meeting
2014 ASCO Annual Meeting
Differential expression of LKB1, PD-L1, and PD-L2 in KRAS-mutant non-small cell lung cancer in never-smokers.
Authors
Antonio Calles
Dana-Farber Cancer Institute, Boston, MA
Antonio Calles , Xiaoyun Liao , Lynette M. Sholl , Mohit Butaney , Scott J. Rodig , Gordon James Freeman , Christine A. Lydon , Geoffrey R. Oxnard , David Michael Jackman , Pasi A. Janne
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Highlights Session
Session Title
Lung Cancer - Non-small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 8032)
DOI
10.1200/jco.2014.32.15_suppl.8032
Abstract #
8032
Poster Bd #
47
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
First Author: Sascha Ansen
Poster
2017 ASCO Annual Meeting
Immune marker profiling and PD-L1, PD-L2 expression mechanisms across non-small cell lung cancer mutations.
First Author: Maria Toki
Poster
2014 ASCO Annual Meeting
Phenformin combines with selumetinib in targeting KRAS mutant non-small cell lung cancer cells with alternative LKB1 status.
First Author: Jun Zhang
Poster
2023 ASCO Annual Meeting
Co-mutational status and PD-L1 expression in KRAS mutant non-small cell lung cancer (NSCLC): Role in treatment selection and association with clinical outcomes.
First Author: Hina Khan